Parkinson's Disease
> Domain Therapeutics has granted Geneva-based Prexton Therapeutics an exclusive option to license and develop metabotropic glutamate receptor 4 (mGluR4) Positive Allosteric Modulator (PAM) drugs targeting Parkinson's disease. Release
> A new target could help reduce the toll Parkinson's disease takes on the brain. Release
Cancer
> Scientists claim to have developed a way to make large quantities of a new promising cancer treatment that targets and kills cancer cells differently than current therapies. Release
> New research shows that the more advanced colorectal cancer cells are, the more grape seed extract inhibits their growth and survival. Release
And Finally… Genetics may be behind two childhood leukemia subtypes. Release | Abstract